Matthew Frank

Title: The Innovative Contributions of Matthew Frank

Introduction

Matthew Frank is a notable inventor based in Palo Alto, California. He has made significant strides in the field of nucleic acid delivery, showcasing his expertise through his innovative patent. His work is particularly relevant in the context of advancing medical and biotechnological applications.

Latest Patents

Matthew Frank holds a patent for "Hybrid immolative cell-penetrating complexes for nucleic acid delivery." This patent outlines complexes, compositions, and methods designed to facilitate the delivery of nucleic acids into cells in vivo. The innovations presented in this patent aim to enhance the complexation, protection, delivery, and release of oligonucleotides and polyanionic cargos into target cells, tissues, and organs, both in vitro and in vivo.

Career Highlights

Matthew Frank is affiliated with Leland Stanford Junior University, where he contributes to research and development in his field. His work at the university allows him to collaborate with other leading experts and engage in cutting-edge research.

Collaborations

Among his notable coworkers are Tim R. Blake and Robert M. Waymouth. Their collaboration fosters an environment of innovation and shared knowledge, further enhancing the impact of their research.

Conclusion

Matthew Frank's contributions to the field of nucleic acid delivery through his patent demonstrate his commitment to advancing scientific knowledge and technology. His work continues to influence the landscape of biotechnological research and applications.